It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.
2007 | New Delhi, Delhi, India | ActiveSparshmart Pharmaceuticals Private Limited, a active private limited company, was established on 24 May 2007 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909DL2007PTC163921. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.40 M and a paid-up capital of ₹1.73 M.
Formerly known as Sparsh Career Network Private Limited. It upholds a compliant status. Its leadership includes Basant Goel (Director), Tripti Goel (Director). Past directors included Usha Goel, Babita Garg, Basant Goel. It holds ₹5.10 Cr open charges and ₹14.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-25,Second Floor Okhla Industrial Area, Phase-Ii, New Delhi, Delhi, 110020.
U51909DL2007PTC163921
163921
24 May 2007
₹2.40 M
₹1.73 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sparshmart Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Basant Goel | Director | 06 Nov 2020 | Current |
| Tripti Goel | Director | 06 Nov 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
| Pramod Abcsdd | Director | 10 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 17 Nov 2020 | Past |
| Pramod Abcsdd | Director | 16 Mar 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sparshmart Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 12.04% decrease in profit. The company's net worth moved up by a moderate rise of 2.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sparshmart Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹51,000,000.00
₹144,760,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2024 | Axis Bank Limited | ₹5.10 Cr | Open |
| 14 Aug 2020 | Others | ₹1.48 Cr | Satisfied |
| 27 Aug 2014 | Others | ₹10.00 Cr | Satisfied |
| 05 Jan 2013 | Vijaya Bank | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sparshmart Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sparshmart Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparshmart Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 14 Aug 2020 via Charge ID 100362343 with Others was fully satisfied on 29 Jul 2025. was completed.
A charge registered on 27 Aug 2014 via Charge ID 10517436 with Others was fully satisfied on 29 Jul 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited of Rs. 51.00 M registered on 11 May 2024 with Charge ID 100968949 was modified on 25 Feb 2025. was completed.
The activity Sparshmart Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 51.00 M with Charge ID 100968949 was registered on 11 May 2024. was documented.
The activity Sparshmart Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The CIN of Sparshmart Pharmaceuticals Private Limited is U51909DL2007PTC163921.
Sparshmart Pharmaceuticals Private Limited is headquartered at B-25,Second Floor Okhla Industrial Area, Phase-Ii, New Delhi, Delhi, 110020.
Sparshmart Pharmaceuticals Private Limited was incorporated on 24 May 2007.
The current directors of Sparshmart Pharmaceuticals Private Limited are
The primary industry of Sparshmart Pharmaceuticals Private Limited is Trade.
Sparshmart Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sparshmart Pharmaceuticals Private Limited is ₹2.40 M, and the paid-up capital is ₹1.73 M.
The compliance status of Sparshmart Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX